Phenylketonuria Treatment Market Size, Share & Trends Analysis Report By Drug (Kuvan, Palynziq), By Mode of Administration (Oral Administration, Parenteral Administration), By Region, And Segment Forecasts, 2025 - 2030

Phenylketonuria Treatment Market Size, Share & Trends Analysis Report By Drug (Kuvan, Palynziq), By Mode of Administration (Oral Administration, Parenteral Administration), By Region, And Segment Forecasts, 2025 - 2030


Grid-scale Battery Storage Market Growth & Trends

The global grid-scale battery storage market size is estimated to reach USD 43.97 billion by 2030, expanding at a CAGR of 27.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. An increase in the number of grid infrastructure, government initiatives, and investments to develop battery technologies and its storage capacity will propel the overall demand.

Increasing awareness among consumers, expanded deployment, utility sectors, technological advancements, and a push from various governments to adopt clean power energy generated by renewable sources are few factors that drive the demand for grid-scale battery storage across the globe. The market in North America accounted for around 21.09% of the global share in 2019.

Asia Pacific is anticipated to register the fastest CAGR from 2020 to 2027 owing to rapid urbanization, transmission & distribution system, increasing industrialization, and subsidies provided by the government for grid-scale battery storage capacity, mainly in the developing countries of India, China, and Singapore.

Considerable developments and investments in renewable energy projects are driving down the cost of lithium-ion batteries, thus increasing the demand for grid-scale storage batteries. The expansions in the grid-scale battery storage are being determined by upgradation of infrastructures, with favorable regulation, and improving system costs. However, exploring of new geographical markets and help in opening of the need for energy storage systems will spur the market development.

Grid-scale Battery Storage Market Report Highlights
  • The lithium-based battery led the market and accounted for the largest revenue share of 85.0% in 2024.
  • Other battery types include Sodium sulphur batteries, flow batteries. These batteries are expected to gain market share during the forecast period
  • Asia Pacific region is projected to expand at the highest CAGR during the forecast period. China is expected to account for the maximum share in the regional market, in terms of revenue
  • The North America grid-scale battery storage market is expected to grow at a CAGR of 27.2% over the forecast period, owing to favorable government policies, technological advancements, and increasing investments in renewable energy.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug
1.2.2. Mode of Administration
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Phenylketonuria Treatment Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Phenylketonuria Treatment Market: Drug Business Analysis
4.1. Drug Market Share, 2024 & 2030
4.2. Drug Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug, 2018 to 2030 (USD Million)
4.4. Kuvan
4.4.1. Kuvan market, 2018 - 2030 (USD Million)
4.5. Palynziq
4.5.1. Palynziq market, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others market, 2018 - 2030 (USD Million)
Chapter 5. Phenylketonuria Treatment Market: Mode of Administration Business Analysis
5.1. Mode of Administration Market Share, 2024 & 2030
5.2. Mode of Administration Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Mode of Administration, 2018 to 2030 (USD Million)
5.4. Oral Administration
5.4.1. Oral administration market, 2018 - 2030 (USD Million)
5.5. Parenteral Administration
5.5.1. Parenteral administration market, 2018 - 2030 (USD Million)
Chapter 6. Phenylketonuria Treatment Market: Regional Estimates & Trend Analysis by Drug and Mode of Administration
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. U.S. phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. Canada phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. Mexico phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. UK phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. Germany phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. France phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. Italy phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Spain phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework
6.5.7.3. Competitive insights
6.5.7.4. Denmark phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework
6.5.8.3. Competitive insights
6.5.8.4. Sweden phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework
6.5.9.3. Competitive insights
6.5.9.4. Norway phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. Japan phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. China phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework
6.6.4.3. Competitive insights
6.6.4.4. India phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework
6.6.5.3. Competitive insights
6.6.5.4. Australia phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework
6.6.6.3. Competitive insights
6.6.6.4. South Korea phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework
6.6.7.3. Competitive insights
6.6.7.4. Thailand phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. Brazil phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Argentina phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive insights
6.8.2.4. South Africa phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework
6.8.3.3. Competitive insights
6.8.3.4. Saudi Arabia phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework
6.8.4.3. Competitive insights
6.8.4.4. UAE phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key country dynamics
6.8.5.2. Regulatory framework
6.8.5.3. Competitive insights
6.8.5.4. Kuwait phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. BioMarin
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Synlogic
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. Travere Therapeutics, Inc.
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. DAIICHI SANKYO COMPANY, LIMITED.
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. Codexis, Inc.
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. SOM BIOTECH
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Homology Medicines, Inc. (Q32 Bio Inc.)
7.5.7.1. Overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings